Cargando…
Challenging tumor resistance with less toxic, more effective drug combinations: an example from neuroblastoma
Autores principales: | Gambacurta, Alessandra, Raschellà, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992173/ https://www.ncbi.nlm.nih.gov/pubmed/29880790 http://dx.doi.org/10.1038/s41419-018-0728-1 |
Ejemplares similares
-
Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more
por: Connors, Jean M, et al.
Publicado: (2022) -
WANTED: Better neuroblastoma biomarkers and better stratification
por: London, Wendy B.
Publicado: (2022) -
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
por: Nicolai, S, et al.
Publicado: (2015) -
Impacts of climate change to African indigenous communities and examples of adaptation responses
por: Leal Filho, Walter, et al.
Publicado: (2021) -
Stroke survivors partner in research: a case example of collaborative processes
por: Kwok, Alyson, et al.
Publicado: (2022)